Exhibit 107
Calculation of Filing Fee Tables
S-3
(Form Type)
TriSalus Life Sciences, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered
| Security Type | Security Class Title | Fee Calculation Rule | Amount Registered(1) | Proposed Maximum Offering Price Per Share | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |
| Newly Registered Securities | ||||||||
| Fees to Be Paid | Equity | Common Stock, par value $0.0001 per share | 457(c) | 10,587,582(2) | $4.08(3) | $43,197,334.60 | $0.00015310 | $6,613.51 |
| Total Offering Amounts | $43,197,334.60 | $6,613.51 | ||||||
| Total Fees Previously Paid | — | |||||||
| Total Fee Offsets | — | |||||||
| Net Fees Due | $6,613.51 | |||||||
| (1) | Includes an indeterminable number of additional securities that, pursuant to Rule 416 under the Securities Act of 1933, as amended, may be issued to prevent dilution from stock splits, stock dividends or similar transactions that could affect the Common Stock to be offered by the selling securityholder. |
| (2) | Represents 10,587,582 shares of Common Stock registered for resale by the selling securityholders identified in this registration statement. |
| (3) | Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended, based on the average of the high and low sales price of the Registrant’s shares of Common Stock as reported on the Nasdaq Stock Market on October 24, 2024. |
